Ledger.Open graph →
SEC Form D · filed March 13, 2014

Theragene Pharmaceuticals, Inc

Offering
$2.0M
Sold
$348K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Jon Berglin · San Diego, CAExec · DirectorSteven Davis · San Diego, CADirectorDaniel Coury · San Diego, CADirectorChaojie Zhang · San Diego, CADirectorPatrick Holdmeyer · Washington, MODirectorJason C. Elliott · DALLAS, TXDirectorThomas E. Burson · DALLAS, TXDirectorKenneth S. Canon · DALLAS, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗